AstraZeneca PLC (AZN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 78.18 |
| Open | 78.13 |
| Bid | 78.51 x 200 |
| Ask | 78.55 x 200 |
| Day's Range | 78.08 - 78.89 |
| 52 Week Range | 60.47 - 79.36 |
| Volume | |
| Avg. Volume | 5,284,995 |
| Market Cap | 244.589B |
| Beta (5Y Monthly) | 0.16 |
| PE Ratio (TTM) | 38.69 |
| EPS (TTM) | 2.03 |
| Earnings Date | Jul 25, 2024 |
| Forward Dividend & Yield | 1.45 (1.85%) |
| Ex-Dividend Date | Feb 22, 2024 |
| 1y Target Est | 82.74 |
ZacksPharma Stock Roundup: AZN's 2030 Sales Target, PFE's New Cost Cut Plan & More
AstraZeneca (AZN) announces an ambitious target of achieving $80 billion in revenues by 2030. Pfizer (PFE) announces a multi-year, multi-phase cost reduction program.
Simply Wall St.Here's Why We Think AstraZeneca (LON:AZN) Is Well Worth Watching
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...
Business WireAstraZeneca demonstrates commitment to patients living with amyloidosis at the 2024 International Symposium on Amyloidosis (ISA)
WILMINGTON, Del., May 23, 2024--AstraZeneca and Alexion, AstraZeneca Rare Disease, will showcase 14 studies, including real-world evidence (RWE), from their portfolio and pipeline of investigational amyloidosis therapies at the International Symposium on Amyloidosis (ISA), in Rochester, MN from May 26–30, 2024.
© 2024 Yahoo. All rights reserved.